Alan M. Ducatman, MD, MSc

Professor in the West Virginia University School of Public Health

Professor Emeritus

Organization:

West Virginia University School of Public Health

Department:

Occupational and Environmental Health Sciences

Classification:

Faculty

• MD, Wayne State University
• MS, CUNY/Hunter College

Tanghal R, Beglarian E, Stem A, Aung M, Alderete T, Ducatman A, Vasiliou V, McConnell R, Conti D, Chatzi L. Exposure to Per- and Polyfluoroalkyl Substances and Liver Cancer: A Systematic Review of Animal and Epidemiological Studies. Environmental Science and Technology. 2026 Feb 3;60(4):2816-2831 DOI: 10.1021/acs.est.5c05535 PMID: 41543329 PMCID: PMC12875370

Khalil N, Hamdaoui L, Ducatman A Koskela A, Lee M, Nahhas RW. Glyphosate exposure, bone mineral density, osteoporosis, and fractures in the United States population. Journal of Environmental Health Science and Engineering. 2026 Jan 16;24(1):3. DOI: 10.1007/s40201-025-00969-7
PMID: 41551845 PMCID: PMC12811184

Li S, Chen JC, Costello E, Walker DI, Goodrich JA, Dara L, Golden-Mason L, Maretti-Mira AC, Bartell SM, Vieira VM, Alderete TL, Goran MI, Chen Z, Gilliland FD, Baumert BO, Rock S, Ducatman A, Eckel SP, Conti DV, McConnell R, Chatzi L. Associations between per-and polyfluoroalkyl substances and metabolic dysfunction-associated steatotic liver disease in adolescents and young adults: modifying roles of age, lifestyle factors, and PNPLA3 genotype. Environmental Research. 2025 Nov 12 https://authors.elsevier.com/sd/article/S0013-9351(25)02573-3

Bartolotta P, Ducatman A, Ioverno E, Olivieri A, Saugo M. Backward and historical PFOA Exposure estimation in an adult population highly exposed in the Veneto region. Environments. 2025. https://www.mdpi.com/2076-3298/12/9/291

Niu S, Dong Z, Zhang y, Ng C, Ducatman A: Impact of per and polyfluoroalkyl substances exposure on statin medication efficacy: clinical and public health implications. Medicine Plus. 2025 https://doi.org/10.1016/j.medp.2024.100069

Criswell R, Fleisch AF, Ducatman A. Viewpoint. Clinical implications of new drinking water regulation for “Forever Chemicals.” JAMA. 2024. Sep 10:332 (10) 785-786 doi: 10.1001/jama.2024.12705

Olivieri A, Saugo M, Ioverno E Bertola F, Pasinato A, Ducatman A. Comment on “Determinants of PFOA serum half-life after end of exposure: A longitudinal study on highly exposed subjects in the Veneto region.” Letter to the editor. Environmental Health Perspectives. 2024 July; 132(6) https://doi.org/10.1289/EHP15099

Saugo M, Ioverno E, Olivieri A, Bertola F. Pasinato A, Ducatman A. PFOA and testis cancer in the Veneto Region (Italy). Letter to the editor. Environmental Health 2024 Mar; 28:23(1)33 https:// 10.1186/s12940-024-01064-4

Khoshakhlagh AH, Yazdanirad S, Ducatman A. Climatic conditions and concentrations of BTEX compounds in atmospheric media. Environmental Research 2024 Jun 15:25 1118533 https://doi.org/10.1016/j.envres.2024.118553

Ducatman A, Chatzi L. Invited Perspective. Per- and polyfluoroalkyl substances, hepatotoxicity, and liver disease: Evidence and clinical responses. Medical Research Archives. 2023 https://doi.org/10.18103/mra.v11i12.4819

Zhao L, Zhang X, Ducatman A, Zhang X. Associations between per-and polyfluoroalkyl substances and adolescent non-alcoholic fatty liver disease. Letter to the editor. Journal of Hepatology 2023: S0168-8278(23)04987-5. PMID: 37487931 doi: 10.1016/j.jhep.2023.07.008

Niu S, Cao Y, Chen R, Bedi M, Sanders AP, Ducatman A, Ng C. Pharmacokinetic modeling of PFAS by kidney transport proteins: Implications for kidney function in health and disease. Environmental Health Perspectives 2023 July; 131(7): 76002 PMCID: PMC10328216 DOI: 10.1289/EHP11885

Jain RB, Ducatman A. Factors affecting serum PFAS concentrations among US females with surgically and naturally induced menopause. Data from NHANES 2003-2018. Environmental Science and Pollution Research International 2023 Jun 27 PMID: 37369902 DOI: 10.1007/s11356-023-28395-y
.
Ducatman A, Tan Y, Nadeau B, Steenland K. Perfluorooctanoic acid (PFOA) exposure and abnormal alanine aminotransferase: Using clinical consensus cutoffs compared to statistical cutoffs for abnormal values. Toxics 2023 May 10;11(5) PMCID: PMC10222185 https://doi.org/10.3390/toxics11050449
Zhang X, Zhao L, Ducatman A, Deng C, von Stackelberg KE, Danforth CJ, Zhang X. Per- and polyfluoroalkyl substances and fatty liver disease and liver function markers in the US adults: NHANES 2017-2018. JHEP Reports 2023 Feb 3;5(5) PMCID: PMC10033989 DOI: 10.1016/j.jhepr.2023.100694

Ma G, Ducatman A. Perfluoroalkyl substance serum concentrations and cholesterol absorption-inhibiting medication ezetimibe. Toxics 2022 Dec: 10 (12):799 https://doi.org/10.3390/toxics10120799

Heibati B, Jaakkola MS, Lajunen Tk, Ducatman A, Veysi R, Karimi A, Jaakkola JJK. Do hospital workers experience a higher risk of respiratory symptoms and loss of lung function? BMC Pulmonary Medicine.2022 Aug 822(1): 303 PMCID: PMC9358815 DOI: 10.1186/s12890-022-02098-5

Jain RB, Ducatman A. Associations of serum perfluoroalkyl substances with concentrations of blood manganese and selenium. Environmental Science and Pollution Research 2022: Dec; 29 (60) 90098-90197 PMID 35864399 doi: 10.1007/s11356-022-22089-7

Jain RB, Ducatman A. Serum concentrations of selected perfluoroalkyl substances for US females compared to males as they age. Science of the Total Environment 2022 Oct 10; 842: 156891 PMID: 35595139 doi: 10.1016/j.scitotenv.2022.156891

Jain RB, Ducatman A. Associations between the concentrations of α-klotho and selected perfluoroalkyl substances in the presence of eGFR based kidney function and albuminuria: Data for US adults aged 40-79 years. Science of the Total Environment 2022 10; 838(Pt.1): 155994 PMID: 35595139 doi: 10.1016/j.scitotenv.2022.155994

Ducatman A, Lapier J, Fuoco R, DeWitt JC. Official health communications are failing PFAS-contaminated communities. Environ Hlth 2022; 21(1): 51 PMID 35538533 doi: 10.1186/s12940-022-00857-9

Ducatman A, Fenton S. Invited Perspective. PFAS and Liver Disease. Bringing all the evidence together. Environmental Health Perspectives 2022; 130(4): 41303: PMID 35475651 doi: 10.1289/EHP11149.

Koskela A, Ducatman A, Schousboe JT, Nahhas RW, Khalil N. Perfluoroalkyl substances and abdominal aortic calcification. J Occup Environ Med 2022; 64(4): 287-294 PMID 35001069 doi: 10.1097/JOM.0000000000002479

Ducatman A, Luster M, Fletcher T. Perfluoroalkyl substance excretion: Effects of organic anion-inhibiting and resin-binding drugs in a community setting. Environmental Toxicology and Pharmacology 2021; 85:103650. PMID 33819618 doi: 10.1016/j.etap.2021.103650

Dr. Alan Ducatman's research interests include occupational and environmental toxicity and prevention of diseases potentially related to environmental exposures. His current environmental research focuses on the human population aspects of perfluorocarbon exposure. Similarly, Dr. Ducatman’s clinic provides diagnostic and intervention advice to patients concerned with exposure to toxins. Dr. Ducatman also collaborates with clinical laboratory scientists and clinicians to create comparative effectiveness research for laboratory utilization practices. For both types of research, his aspiration is to improve the health of populations.

Dr. Ducatman served as Interim Founding Dean, School of Public Health, at the West Virginia University Health Sciences Center. The School of Public Health is the first fully new school/college at WVU in 50 years. He was also the chair of the WVU Department of Community Medicine for 15 years, and director of WVU’s Occupational Medicine residency program..

Dr. Ducatman received the MD degree from Wayne State University and the MSc in Environmental Health from the City University of New York. He completed his residency training at Brown University and at the Mayo Clinic, and he is board-certified in Internal Medicine and in Occupational Medicine. His national leadership history includes service as Chair, Residency Review Committee in Preventive Medicine, Accreditation Council for Graduate Medical Education. He has also served as Chair, Board of Scientific Counselors, National Environmental Health Center and Agency for Toxic Substances and Disease Registry, U.S. Centers for Disease Control and Prevention. Dr. Ducatman is a frequent consultant to industry, government, nonprofit organizations, and patient or community groups regarding occupational and environmental health, and public health interventions. He currently serves as a member of the West Virginia Governor’s Advisory Council on Substance Abuse.

Occupational and Environmental Health

Dr. Alan Ducatman’s research involves the following:

1) Health outcomes following environmental exposures of human populations

2) Use of secondary data to address environmental health questions

3) Participation in teams that evaluate local health outcomes near point sources

4) Experience with many phases of extractive industries related to energy

5) Environmental perfluorocarbon exposure, and related biomarkers of human physiologic response 

I am board certified in Internal Medicine, and in Occupational (Preventive) Medicine.  I maintain an active clinical consultation practice with a large geographic referral base, which informs my research in the environment and community responses to the stressors of living near industrial operations. I am accustomed to participating in multi- and interdisciplinary teams who address exposure-outcome questions of national importance. 

Grants Submitted:

Cove Point Maryland Liquified Natural Gas Facility Project

PI: Michael Mccawley
Sponsor: US DHHS-NIH-National Institute of Environmental Health Sciences
Deadline Date: 08/01/2016

Brownfield-to-Trail Redevelopment

PI:  Christiaan Abildso

Sponsor:  ATSDR

Deadline Date 7/05/2016

Recent Grants Completed:

Translating Research into Improved Practice in rural Access Hospitals

PI:  Alan Ducatman

Sponsor:  Claude Worthington Benedum Foundation

Completion Date:  Dec 15, 2015

Medical Specialties

• Occupational Medicine

Board Certifications

• Internal Medicine, American Board of Internal Medicine
• Occupational Medicine, American Board of Preventive Medicine